Mavacoxib

Mavacoxib is a long-acting non-steroidal anti-inflammatory substance (NSAID) used for managing chronic inflammatory conditions in animals, such as osteoarthritis. Read more

Mavacoxib is a long-acting non-steroidal anti-inflammatory substance (NSAID) used for managing chronic inflammatory conditions in animals, such as osteoarthritis.

Essential insights

• COX-2 Inhibition: Mavacoxib works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which plays a key role in producing prostaglandins involved in inflammation and pain.
• Minimal COX-1 Activity: By minimizing COX-1 inhibition, the risk of side effects such as gastrointestinal damage and impaired renal function is reduced, as COX-1 is essential for normal physiological processes.
• Extended Half-life: Its prolonged half-life ensures sustained efficacy, reducing the need for frequent dosing.
• Safety and Side Effects: Mavacoxib is generally well tolerated, but caution is advised in animals with compromised liver or kidney function.